RN7SL415P

Across TCGA pan-cancer cohorts, RN7SL415P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL415P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL415P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL415P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRC, ACC, and KICH are the cancer types where RN7SL415P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.376	0.649	<.001	108	view →
ACC	OS	Tertile	All	0.114	0.638	<.001	90	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	63	view →
READ	DFS	Tertile	All	0.269	0.819	.009	45	view →
LUSC	OS	Tertile	II,III,IV	0.431	0.788	.009	27	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →
UCS	OS	Tertile	All	0.231	0.589	.033	18	view →
ESCA	DFS	Tertile	III,IV	0.751	0.269	.021	18	view →
LGG	DFS	Tertile	All	0.261	0.426	.031	9	view →
LIHC	OS	Tertile	III,IV	0.119	0.535	.035	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL415P–KIRC (OS)

Open the KIRC breakdown →